Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Sullivan

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
American Journal of Physiology. Heart and Circulatory Physiology|June 24, 2008
Polymerized bovine hemoglobin decreases oxygen delivery during normoxia and acute hypoxia in the ratDavid C Irwin, Ben Foreman, Ken Morris, et al.
Organic & Biomolecular Chemistry|January 8, 2013
Design of synthetic oligoribonucleotide-based agonists of Toll-like receptor 3 and their immune response profiles in vitro and in vivoTao Lan, Daqing Wang, Lakshmi Bhagat, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 26, 2012
Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanismPaul W Buehler, Jin Hyen Baek, Christina Lisk, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 2007
Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8Tao Lan, Ekambar R Kandimalla, Dong Yu, et al.
Clinical Immunology (Orlando, Fla.)|November 24, 2016
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasisDeepak M W Balak, Martijn B A van Doorn, Robert D Arbeit, et al.
Free Radical Biology & Medicine|April 11, 2009
A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leakDavid C Irwin, Joe M McCord, Eva Nozik-Grayck, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2011
Discovery of potent and specific CXCR3 antagonistsXiaoqi Chen, Jeff Mihalic, Jeff Deignan, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2007
Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3Michael Johnson, An-Rong Li, Jiwen Liu, et al.
Autoimmunity|March 21, 2009
An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammationFergus R Byrne, Aaron Winters, David Brankow, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
American Journal of Physiology. Heart and Circulatory Physiology|June 24, 2008
Polymerized bovine hemoglobin decreases oxygen delivery during normoxia and acute hypoxia in the ratDavid C Irwin, Ben Foreman, Ken Morris, et al.
Organic & Biomolecular Chemistry|January 8, 2013
Design of synthetic oligoribonucleotide-based agonists of Toll-like receptor 3 and their immune response profiles in vitro and in vivoTao Lan, Daqing Wang, Lakshmi Bhagat, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 26, 2012
Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanismPaul W Buehler, Jin Hyen Baek, Christina Lisk, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 2007
Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8Tao Lan, Ekambar R Kandimalla, Dong Yu, et al.
Clinical Immunology (Orlando, Fla.)|November 24, 2016
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasisDeepak M W Balak, Martijn B A van Doorn, Robert D Arbeit, et al.
Free Radical Biology & Medicine|April 11, 2009
A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leakDavid C Irwin, Joe M McCord, Eva Nozik-Grayck, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2011
Discovery of potent and specific CXCR3 antagonistsXiaoqi Chen, Jeff Mihalic, Jeff Deignan, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2007
Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3Michael Johnson, An-Rong Li, Jiwen Liu, et al.
Autoimmunity|March 21, 2009
An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammationFergus R Byrne, Aaron Winters, David Brankow, et al.
Pageof 3